Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 3
1952 1
1953 1
1954 3
1955 3
1958 1
1963 4
1964 3
1965 7
1966 1
1967 4
1968 2
1969 4
1970 5
1971 8
1972 4
1973 10
1974 10
1975 4
1976 6
1977 5
1978 4
1979 4
1980 1
1981 3
1982 6
1983 4
1984 1
1985 3
1986 4
1987 3
1988 4
1989 10
1990 5
1991 6
1992 6
1993 4
1994 11
1995 9
1996 13
1997 6
1998 5
1999 3
2000 11
2001 12
2002 11
2003 21
2004 18
2005 32
2006 33
2007 32
2008 58
2009 58
2010 66
2011 59
2012 80
2013 108
2014 141
2015 166
2016 175
2017 237
2018 288
2019 324
2020 350
2021 312
2022 391
2023 297
2024 105

Text availability

Article attribute

Article type

Publication date

Search Results

3,100 results

Results by year

Filters applied: . Clear all
Page 1
Psoriasis and Treatment: Past, Present and Future Aspects.
Reid C, Griffiths CEM. Reid C, et al. Acta Derm Venereol. 2020 Jan 30;100(3):adv00032. doi: 10.2340/00015555-3386. Acta Derm Venereol. 2020. PMID: 31971601 Free PMC article. Review.
The management of psoriasis has evolved considerably over the past 100 years. This has occurred in parallel with our understanding of the pathogenesis of this common, complex and enigmatic disease. ...With precise targeting of immune pathways for the treatment of psoria …
The management of psoriasis has evolved considerably over the past 100 years. This has occurred in parallel with our understanding of …
Psoriasis and Co-morbidity.
Amin M, Lee EB, Tsai TF, Wu JJ. Amin M, et al. Acta Derm Venereol. 2020 Jan 30;100(3):adv00033. doi: 10.2340/00015555-3387. Acta Derm Venereol. 2020. PMID: 31971602 Free PMC article. Review.
Psoriasis is associated with multiple co-morbid medical conditions. ...Of 2,499 records identified, 28 met our criteria selection and were included in this review. The relationships between psoriasis and these multiple comorbid disease conditions are discussed and a …
Psoriasis is associated with multiple co-morbid medical conditions. ...Of 2,499 records identified, 28 met our criteria selection and …
Generalized pustular psoriasis: a review and update on treatment.
Hoegler KM, John AM, Handler MZ, Schwartz RA. Hoegler KM, et al. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1645-1651. doi: 10.1111/jdv.14949. Epub 2018 Apr 11. J Eur Acad Dermatol Venereol. 2018. PMID: 29573491 Review.
Generalized pustular psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring cutaneous manifestations with sepsis-like systemic symptoms. ...The interleukin family and caspase recruitment domain family have been impli …
Generalized pustular psoriasis (GPP) is a subtype of pustular psoriasis characterized by painful and occasionally disfiguring …
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
Kamata M, Tada Y. Kamata M, et al. Int J Mol Sci. 2020 Mar 1;21(5):1690. doi: 10.3390/ijms21051690. Int J Mol Sci. 2020. PMID: 32121574 Free PMC article. Review.
Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. ...In addition, we discuss the impact of biologics on comorbidities caused by psoriasis....
Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. ...In addition, we discuss the impact of …
Current Developments in the Immunology of Psoriasis.
Grän F, Kerstan A, Serfling E, Goebeler M, Muhammad K. Grän F, et al. Yale J Biol Med. 2020 Mar 27;93(1):97-110. eCollection 2020 Mar. Yale J Biol Med. 2020. PMID: 32226340 Free PMC article. Review.
Psoriasis is a frequent inflammatory skin disease. Fundamental research on the pathogenesis of psoriasis has substantially increased our understanding of skin immunology, which has helped to introduce innovative and highly effective therapies. ...We describe differe …
Psoriasis is a frequent inflammatory skin disease. Fundamental research on the pathogenesis of psoriasis has substantially inc …
Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications.
Wang J, Wang YM, Ahn HY. Wang J, et al. AAPS J. 2014 Sep;16(5):938-47. doi: 10.1208/s12248-014-9637-0. Epub 2014 Jul 4. AAPS J. 2014. PMID: 24993574 Free PMC article. Review.
Currently approved biological products for psoriasis treatment fall into two main classes: cytokine modulators and biologics targeting T cells. ...Elevated proinflammatory cytokines can suppress some cytochrome P450 (CYP) enzymes, and the treatment of psor …
Currently approved biological products for psoriasis treatment fall into two main classes: cytokine modulators and biol …
From Empirical to Pathogenesis-Based Treatments for Psoriasis.
van de Kerkhof PC. van de Kerkhof PC. J Invest Dermatol. 2022 Jul;142(7):1778-1785. doi: 10.1016/j.jid.2022.01.014. Epub 2022 Mar 3. J Invest Dermatol. 2022. PMID: 35249726 Free article. Review.
Understanding of the pathogenesis of psoriasis has evolved into a branching model of innate and acquired immunity. ...Psoriasis research is a showcase par excellence of translational medicine, resulting in pathogenesis-based treatments....
Understanding of the pathogenesis of psoriasis has evolved into a branching model of innate and acquired immunity. ...Psoriasis …
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
Yang K, Oak ASW, Elewski BE. Yang K, et al. Am J Clin Dermatol. 2021 Mar;22(2):173-192. doi: 10.1007/s40257-020-00578-0. Am J Clin Dermatol. 2021. PMID: 33301128 Free PMC article. Review.
Psoriasis is a common inflammatory skin disease with multiple comorbidities, including psoriatic arthritis and coronary artery disease, that can severely impact an individual's quality of life and daily functioning. ...Overall, these highly effective medications are contri …
Psoriasis is a common inflammatory skin disease with multiple comorbidities, including psoriatic arthritis and coronary artery diseas …
Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies.
Mattei PL, Corey KC, Kimball AB. Mattei PL, et al. J Eur Acad Dermatol Venereol. 2014 Mar;28(3):333-7. doi: 10.1111/jdv.12106. Epub 2013 Feb 21. J Eur Acad Dermatol Venereol. 2014. PMID: 23425140 Review.
OBJECTIVE: To perform a systematic review to determine PASI to DLQI correlation. METHODS: RCTs of biological agents for the treatment of moderate-to-severe psoriasis were reviewed in accordance with PRISMA guidelines. ...CONCLUSIONS: Mean PASI and DLQI correlate pre …
OBJECTIVE: To perform a systematic review to determine PASI to DLQI correlation. METHODS: RCTs of biological agents for the treatment …
Old and New Biological Therapies for Psoriasis.
Rønholt K, Iversen L. Rønholt K, et al. Int J Mol Sci. 2017 Nov 1;18(11):2297. doi: 10.3390/ijms18112297. Int J Mol Sci. 2017. PMID: 29104241 Free PMC article. Review.
Biological therapy became available for psoriasis with the introduction of alefacept at the beginning of this century. ...However, significant improvement in outcome was first accomplished with the introduction of tumor necrosis factor-alpha inhibitors that were alr …
Biological therapy became available for psoriasis with the introduction of alefacept at the beginning of this century. ...Howe …
3,100 results